Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, GlaxoSmithKline, Research Triangle Park, NC 27709, USA.

Published: September 2005

Ketoheterocyclic inhibitors of cathepsin K have been disclosed. SAR of potency enhancing P2-P3 groups coupled with ketoheterocyclic warheads to provide cathepsin K inhibitors have been described. In addition, a novel route to access alpha-ketothiazoles using a key thioamide functionality has been disclosed. The mild method employed allows for the presence of diverse functional groups, such as amide and carbamate functionalities, commonly found in protease inhibitors that have peptidomimetic scaffolds. This new method should provide a quick entry into functionally diverse protease inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.05.091DOI Listing

Publication Analysis

Top Keywords

inhibitors cathepsin
8
protease inhibitors
8
ketoheterocycle-based inhibitors
4
cathepsin novel
4
novel entry
4
entry synthesis
4
synthesis peptidic
4
peptidic ketoheterocycles
4
ketoheterocycles ketoheterocyclic
4
inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!